|
|||||
|
|
Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2 |
|
| Authors: | Yejin Jang Jin Soo Shin Myoung Kyu Lee Eunhye Jung Timothy An Uk-Il Kim Kyungjin Kim Meehyein Kim |
| Affiliation: | 1.Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea; (Y.J.); (J.S.S.); (M.K.L.); (E.J.); (T.A.);2.Graduate School of New Drug Discovery and Development, Chungnam National University, Daejeon 34134, Korea;3.Research and Development Center, ST Pharm Co., Ltd., Seoul 01694, Korea; |
| Abstract: | |
| Keywords: | SARS-CoV-2 antiviral activity gemcitabine 2′ -fluoro-2′ -deoxycytidine |
